Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
D000941:Antigens; D002118:Calcium / Q000032:analysis / Q000097:blood / Q000378:metabolism / Q000652:urine; D002128:Calcium Metabolism Disorders / Q000188:drug therapy*; D004100:Dihydroxycholecalciferols / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D005243:Feces / Q000032:analysis; D006801:Humans; D006887:Hydroxycholecalciferols / Q000378:metabolism / Q000627:therapeutic use*; D006934:Hypercalcemia / Q000139:chemically induced; D007413:Intestinal Mucosa / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism* / Q000652:urine; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D014511:Uremia / Q000097:blood / Q000188:drug therapy / Q000378:metabolism / Q000652:urine
D000941:Antigens; D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D010758:Phosphorus; D002118:Calcium